The latest market report published by Credence Research, Inc. “Vitreous Tamponades Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global vitreous tamponades market was valued at US$ 77.2 Mn in 2017 and expected to reach US$ 105.8 Mn by 2026, expanding at a CAGR of 3.5% from 2018 to 2026.
Browse the full report Vitreous Tamponades 2018 – 2026 report at https://www.credenceresearch.com/report/vitreous-tamponades-market
Vitreous tamponades are used in vitrectomy surgeries for reattachment of the retina and treatment of other vitreous deformations. These products are often used for treatment of retinal disorders during retinal surgery and post-surgery recovery measure. Some of the common conditions where vitreous tamponades are sued during treatment are retinitis pigmentosa, diabetic retinopathy, retinal degeneration, retinal detachment, macular hole, macular edema, retinopathy or prematurity, uveitis, vascular occlusion and so on. Vitreous occupies the gap between the eye lens and the retina; and since it cannot regenerate, this cavity needs to be refilled with substitute through surgery. Gas and liquid vitreous tamponades are the ideal choice during surgical interventions.
Stable growth of the global vitreous tamponades market is driven by increasing incidence of retinal conditions such as diabetic retinopathy, retinal detachments, etc. the global incidence of diabetes is increasing, thereby paving way for increased patient pool for diabetic reinopathy, consequently increasing the demand for vitreous tamponades in vitrectomy.
Ongoing developments in the field of vitreoretinal surgery has also augmented the need for appropriate vitreous substitutes. An ideal substitute is expected to maintain all the biochemical and physical characteristics of the natural vitreous. Furthermore, as new surgical techniques with smaller instruments have been introduced in the market with proven safety profiles, there has been a consistent growth in the number of patients opting for such surgeries. This has also led to the use of more viscous vitreous substitutes.
Download Sample research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59588
Growing incidence of vitreoretinal disorders and diabetes complications such as diabetic retinopathy is a key driver of this market. These conditions are treated with vitrectomy which involves removal of the vitreous humor along with replacement with synthetic substitute. Additionally, increasing geriatric population is also considered as one of the prominent factors positively impacting the market growth. Based on the competitive scenario, this market is witnessing presence of a limited number of players, which further enjoy regional dominance.
Key Market Movements:
- Increasing pool of diabetic population, therefore increasing the patient count for diabetic retinopathy
- Improvement in surgical methods and technologies attracting even more patients opting for vitreoretinal surgeries
- Growing awareness in the general population and improving healthcare infrastructure in Asia Pacific market
- Perpetual growth in prevalence of diabetes in key areas such as India and China
Do inquiry before purchase the Industry Research Report @ https://www.credenceresearch.com/inquiry-before-buying/59588
Chapter 4. Global Vitreous Tamponades Market, by Type, 2016 – 2026 (US$ Mn)
4.2. Gas Tamponades
4.2.1. Sulfur Hexafluoride (SF6)
4.2.2. Perfluoroethane (C2F6)
4.2.3. Perfluoropropane (C3F8)
4.3. Liquid Tamponades
4.3.1. Silicone Oil
4.3.2. Perfluorocarbon Liquids (PFCL)
Chapter 5. Global Vitreous Tamponades Market, by Geography, 2016 – 2026 (US$ Mn)
5.2. North America Vitreous Tamponades Market, 2016 – 2026 (US$ Mn)
5.2.1. North America Vitreous Tamponades Market, by Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Vitreous Tamponades Market, by Country, 2016 – 2026 (US$ Mn)
5.3. Europe Vitreous Tamponades Market, 2016 – 2026 (US$ Mn)
5.3.1. Europe Vitreous Tamponades Market, by Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Vitreous Tamponades Market, by Country/Region, 2016 – 2026 (US$ Mn)
18.104.22.168. Rest of Europe
5.4. Asia Pacific Vitreous Tamponades Market, 2016 – 2026 (US$ Mn)
5.4.1. Asia Pacific Vitreous Tamponades Market, by Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Vitreous Tamponades Market, by Country/Region, 2016 – 2026 (US$ Mn)
22.214.171.124. Rest of Asia Pacific
5.5. Latin America Vitreous Tamponades Market, 2016 – 2026 (US$ Mn)
5.5.1. Latin America Vitreous Tamponades Market, by Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Vitreous Tamponades Market, by Country/Region, 2016 – 2026 (US$ Mn)
126.96.36.199. Rest of Latin America
5.6. Middle East & Africa Vitreous Tamponades Market, 2016 – 2026 (US$ Mn)
5.6.1. Middle East & Africa Vitreous Tamponades Market, by Type, 2016 – 2026 (US$ Mn)
5.6.2. Middle East & Africa Vitreous Tamponades Market, by Region, 2016 – 2026 (US$ Mn)
188.8.131.52. Rest of Middle East & Africa
Chapter 6. Company Profiles
6.1. Carl Zeiss Meditec AG
6.1.1. Company Overview
6.1.2. Financial Information (Subject to Data Availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Dutch Ophthalmic Research Center (International) B.V.
6.3. AL.CHI.MI.A Srl
6.4. Valeant Pharmaceuticals International, Inc.
6.5. Fluoron GmbH
6.6. Novartis AG
6.7. Alcon, Inc.
6.8. CROMA-PHARMA GmbH
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith (Global Sales Manager)